Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Oristrell

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 7, 2015
Safety and effectiveness of home intravenous antibiotic therapy for multidrug-resistant bacterial infectionsA Mujal, J Sola, M Hernandez, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|October 30, 2004
[Analysis of a series of 55 patients with biopsy proven giant cell temporal arteritis]E Bustamante Maldonado, B Marí Alfonso, M Monteagudo Jiménez, et al.
Annals of the Rheumatic Diseases|December 1, 1996
Von Willebrand factor in the outcome of temporal arteritisM C Cid, J Monteagudo, J Oristrell, et al.
Annals of the Rheumatic Diseases|June 12, 1999
Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activityB Coll-Vinent, C Vilardell, C Font, et al.
Clinical and Experimental Immunology|October 6, 2020
Relapse rate and renal prognosis in ANCA-associated vasculitis according to long-term ANCA patternsJ Oristrell, J Loureiro-Amigo, R Solans, et al.
British Journal of Rheumatology|December 24, 1997
Circulating soluble adhesion molecules in patients with classical polyarteritis nodosaB Coll-Vinent, J M Grau, A López-Soto, et al.
Arthritis and Rheumatism|January 20, 1998
Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritisM C Cid, C Font, J Oristrell, et al.
Infectious Diseases (London, England)|February 23, 2021
Corticosteroids and tocilizumab reduce in-hospital mortality in severe COVID-19 pneumonia: a retrospective study in a Spanish hospitalE Van den Eynde, O Gasch, J C Oliva, et al.
Clinical and Experimental Rheumatology|June 8, 2010
Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseasesM Ramos-Casals, F J García-Hernández, E de Ramón, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 7, 2015
Safety and effectiveness of home intravenous antibiotic therapy for multidrug-resistant bacterial infectionsA Mujal, J Sola, M Hernandez, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|October 30, 2004
[Analysis of a series of 55 patients with biopsy proven giant cell temporal arteritis]E Bustamante Maldonado, B Marí Alfonso, M Monteagudo Jiménez, et al.
Annals of the Rheumatic Diseases|December 1, 1996
Von Willebrand factor in the outcome of temporal arteritisM C Cid, J Monteagudo, J Oristrell, et al.
Annals of the Rheumatic Diseases|June 12, 1999
Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activityB Coll-Vinent, C Vilardell, C Font, et al.
Clinical and Experimental Immunology|October 6, 2020
Relapse rate and renal prognosis in ANCA-associated vasculitis according to long-term ANCA patternsJ Oristrell, J Loureiro-Amigo, R Solans, et al.
British Journal of Rheumatology|December 24, 1997
Circulating soluble adhesion molecules in patients with classical polyarteritis nodosaB Coll-Vinent, J M Grau, A López-Soto, et al.
Arthritis and Rheumatism|January 20, 1998
Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritisM C Cid, C Font, J Oristrell, et al.
Infectious Diseases (London, England)|February 23, 2021
Corticosteroids and tocilizumab reduce in-hospital mortality in severe COVID-19 pneumonia: a retrospective study in a Spanish hospitalE Van den Eynde, O Gasch, J C Oliva, et al.
Clinical and Experimental Rheumatology|June 8, 2010
Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseasesM Ramos-Casals, F J García-Hernández, E de Ramón, et al.
Pageof 2